Introduction
============

Telemedicine is defined as the use of telecommunication and information technology to provide clinical health care from a distance.[@b1-opth-12-2459] With improvements in technology, Internet, and transfer of information, telemedicine has become established in numerous areas of medicine. This includes multiple areas of health care delivery: consenting, achieving a diagnosis, instituting treatment, disease prevention, and medical research.[@b1-opth-12-2459]--[@b3-opth-12-2459] In ophthalmology, telemedicine (or "teleophthalmology") has been used mainly for screening for glaucoma, cataract, or retinal diseases, providing patients in rural and remote areas with improved access to eye care.[@b2-opth-12-2459],[@b4-opth-12-2459]--[@b6-opth-12-2459] There have also been some recent reports of using teleophthalmology as a therapeutic, rather than just diagnostic tool (eg, teleophthalmology navigated retinal laser therapy), which could have great potential for the future.[@b7-opth-12-2459]

In one of our previous publications, we discussed the consent process for elective refractive surgery, the role of the treating surgeon in the consenting process, and examined if meeting the surgeon prior to the surgery or on the day of surgery affects the patient's perception of consent quality.[@b8-opth-12-2459] We also explored how the consent process can be enhanced with the use of different tools such as video consent, written information, and the involvement of medical personnel other than the treating surgeon.[@b8-opth-12-2459] Since our last publication, new UK General Medical Council guidelines were published and came into effect in June 2016. These require doctors performing cosmetic or refractive interventions to discuss the procedure with their patient ahead of the day of surgery.[@b9-opth-12-2459] This prompted us to change our consenting approach: each patient is required to discuss the procedure with their treating surgeon prior to the day of surgery. Patients have an option to either discuss the procedure remotely (telemedicine) or to have a face-to-face meeting with their surgeon prior to the day of surgery. Each patient, whether they elect to speak to their surgeon via a telemedicine or face-to-face meeting approach, has to undergo a face-to-face examination on the day of surgery prior to any procedure taking place. During this examination, the treating surgeon and patient complete the informed consent process. The aim of this study was to investigate whether these two methods of consenting (remote or in-clinic) have an impact on the patient's perception of consent quality.

Patients and methods
====================

All patients provided informed consent to undergo refractive surgery (LASIK, photorefractive keratometry \[PRK\], or refractive lens exchange \[RLE\]). As a part of their consent process, all patients involved in the study agreed for their data to be used (without patient's identifiers) for statistical analysis and research. The study was deemed exempt from full review by the Committee on Human Research at the University of California, San Francisco because it used only retrospective, de-identified patient data, and followed the principles of the Declaration of Helsinki.

Clinical data and patient questionnaire outcomes were exported from Optical Express electronic medical records for all patients who underwent laser vision correction (LVC) or RLE (corrected distance visual acuity \[CDVA\] not worse than 20/40) between January and December 2017, attended day 1 and 1-month postoperative follow-up visit, and completed a questionnaire.

Patients first underwent a preoperative consultation with an experienced refractive optometrist in their local clinic, which involved clinical examination, discussion, and diagnostic measurements. The refractive optometrist first assessed the patient's medical and ocular history, occupation, hobbies, and general expectations from refractive surgery. The clinical examination involved a manifest refraction, cycloplegic refraction, uncorrected distance visual acuity (UDVA) and CDVA, external ocular exam, ocular motility, confrontational visual fields, biomicroscopic exam, dilated fundoscopy, and diagnostic scans (corneal topography: Pentacam; Oculus Inc., Arlington, WA, USA; wavefront aberrometry: iDesign Advanced Wave Scan System; Johnson & Johnson Vision Care, Inc, Jacksonville, FL, USA; noncontact tonometry/autorefraction).

Based on the consultation, the optometrist made a preliminary determination of whether the patient met all the suitability criteria for refractive surgery and discussed the most appropriate procedure (LASIK, PRK, or RLE). The optometrist then discussed the benefits of the proposed surgery, possible complications, side effects, and postoperative expectations, and answered all the patient's questions. The patient was also provided written information consisting of the informed consent document, information about the procedure, preoperative preparation, and postoperative aftercare.

All patients watched an educational video, which reiterated all the points discussed with the optometrist. At the conclusion of the video, the patient and the optometrist completed an electronic signature section within the Electronic Medical Records system to confirm the patient's understanding of the proposed procedure, potential risks, and range of associated outcomes in addition to the benefits and alternatives. RLE candidates had a detailed discussion about intraocular lens types and their possible side effects and underwent further diagnostic tests (biometry for lens calculation: IOLMaster; Carl Zeiss Meditec AG, Jena, Germany; retinal optical coherence tomography: Cirrus 4000/500 OCT; Carl Zeiss Meditec AG; and specular microscopy: SP 2000P specular microscope; Topcon Europe BV, Tokyo, Japan).

All patients then had an option to either meet their surgeon prior to the day of surgery in person ("in-clinic" group) or to arrange a telephone discussion with the surgeon ("remote" group). Patient's choice determined the type of consent, but there was a small group of patients with certain conditions that were required to attend in-clinic consent, and these patients were excluded from this study. In-clinic consent was necessary in all patients (RLE and LVC) with significant corneal scars (CDVA ≤20/25), corneal dystrophy (Fuchs, guttata, map-dot-fingerprint dystrophy, etc), family history of keratoconus, and any suspicious corneal shape (superior-- inferior keratometry difference on Pentacam saggital map \[4 mm diameter\] \>1.4 D or any other signs of abnormal or irregular topography). Additionally, for RLE patients, it was mandatory to attend in-clinic consent if they: were younger than 50 years with myopia \>6.0 D, were younger than 40 years (regardless of the refractive error), had low distance prescription presbyopes (defined as UDVA of 20/25 or better in each eye), and had retinal pathology reducing CDVA to ≤20/25 (eg, signs of age-related macular degeneration, drusen, epiretinal membrane, etc).

All patients who participated in an in-clinic consent had a discussion and ophthalmic examination performed by their surgeon on the day of their consultation and a further examination performed on the day of surgery. All patients in the remote group had a discussion with the surgeon over the phone and an ophthalmic examination performed by the treating surgeon on the day of surgery. Prior to the remote discussion, surgeons had access to the patient's electronic file and reviewed outcomes of all scans and measurements obtained by the optometrist in their local clinic. In both cases (in-clinic and remote), patients were encouraged to have their consent discussion at least 7 days prior to surgery, and if this was not possible, a minimum 48-hour reflection period was required. Each step of the consent process (discussion with an optometrist, video consent, discussion with the surgeon) culminated in signing an electronic declaration, where the patient confirmed understanding all main points of the discussion. Patient who had a remote consent discussion received a web link asking them to confirm that the discussion took place.

Except for patients with known conditions described above, patients could choose between the two types of consent (in-clinic or remote); however, they were always encouraged to meet their surgeon ahead of the day of surgery and this appointment did not incur any extra cost.

Postoperatively, patients were scheduled for 1-day, 1-week, and 1-month follow-up visits were they were clinically examined and completed a postoperative questionnaire. The methodology of obtaining the questionnaire has been previously described.[@b8-opth-12-2459] The questionnaire was strictly confidential, and patients were informed that their responses were not made available to the treating surgeon and were not accessible to any clinic personnel. All questions from the patient questionnaire used for statistical analysis are listed in [Table 1](#t1-opth-12-2459){ref-type="table"}.

Statistical analysis
--------------------

All calculations and statistical analysis were performed using SAS 9.3 (SAS Institute Inc., Cary, NC, USA) and Microsoft Office Excel 11.0 (Microsoft Corporation, Redmond, WA, USA) software. Preoperative and 1-month postoperative data between in-clinic and remote groups of patients were compared using an unpaired *t*-test and a chi-squared test was applied for the comparison of percentages.

A multivariate regression model was developed to find independent predictors of the outcomes of question 3 ([Table 1](#t1-opth-12-2459){ref-type="table"}): "Do you feel you were properly consented for surgery?" Variables included in the regression model were patients demographics (age, gender), preoperative and postoperative clinical data (visual acuity, refractive error), questionnaire outcomes ([Table 1](#t1-opth-12-2459){ref-type="table"}), type of consent (in-clinic vs remote), as well as the number of days between the consent appointment and surgery day. The model was developed using a stepwise generalized linear approach. Detailed steps in model creation have been previously described.[@b8-opth-12-2459]

Results
=======

Of all patients, 19.9% of LVC patients and 52.1% of RLE patients preferred to meet their treating surgeon ahead of the day of surgery, whereas 80.1% of LVC patients and 47.9% of RLE patients opted for a remote consent discussion. [Tables 2](#t2-opth-12-2459){ref-type="table"} (LVC) and 3 (RLE) compare preoperative and 1-month postoperative clinical parameters between in-clinic and remote groups of patients. Patients who opted to meet their treating surgeon ahead of the day of surgery were slightly older and tended to have higher preoperative myopic sphere, higher cylinder, and slightly worse preoperative CDVA ([Tables 2](#t2-opth-12-2459){ref-type="table"} and [3](#t3-opth-12-2459){ref-type="table"}). As expected (due to higher levels of preoperative ametropia), most of the mean postoperative outcomes were worse for patients with in-clinic consent.

Postoperative day 1 questionnaire
---------------------------------

On the first postoperative day, 99.6% of in-clinic LVC patients and 99.3% of remote patients (*P*=0.21) responded by confirming that they were either satisfied or very satisfied with the surgeon's care (question 1, [Table 1](#t1-opth-12-2459){ref-type="table"}). In the RLE group, these percentages were 99.5% and 99.6% for in-clinic and remote groups, respectively (*P*=0.82).

Most of the patients in the LVC group (98.9% of in-clinic patients vs 99.1% of remote patients; *P*=0.64) and RLE group (99.1% in-clinic and 99.4% remote; *P*=0.30) were satisfied or very satisfied that their surgeon answered all of their questions (question 2, [Table 1](#t1-opth-12-2459){ref-type="table"}).

One-month postoperative questionnaire
-------------------------------------

In the LVC group, 97.5% of in-clinic patients and 98.3% of remote patients stated they were properly consented for surgery (question 3) and this slight difference was statistically significant (*P*=0.04). Likewise, the percentages for the RLE group were 97.6% for in-clinic and 97.9% for remote patients (*P*=0.47).

[Figure 1](#f1-opth-12-2459){ref-type="fig"} depicts the postoperative satisfaction with vision ([Table 1](#t1-opth-12-2459){ref-type="table"}, question 4). At the 1-month postoperative aftercare visit, 94.0% of in-clinic and 94.7% of remote LVC patients were "satisfied" (very satisfied or satisfied) with their vision. For RLE patients, these percentages were 90.3% for the in-clinic group and 90.0% for the remote group. There was no statistically significant difference in postoperative satisfaction between the in-clinic and remote patients ([Figure 1](#f1-opth-12-2459){ref-type="fig"}).

Of all LVC patients, 96.0% and 97.0% of in-clinic and remote patients, respectively (*P*=0.05), were willing to recommend the surgery to their friends or relatives (question 5). These percentages were 94.7% for in-clinic and 95.3% for the remote group for RLE patients.

[Table 4](#t4-opth-12-2459){ref-type="table"} summarizes the mean postoperative scores for optical side effects and dry eye (question 6). There was no statistically significant difference between in-clinic and remote patients in any questioned side effect, except for a slight difference in ghosting for LVC patients.

[Figure 2A and B](#f2-opth-12-2459){ref-type="fig"} shows the difficulties patients experienced with various activities (night driving, near vision, or distance tasks; questions 7--9 from [Table 1](#t1-opth-12-2459){ref-type="table"}). Again, no statistically significant difference was found in the outcomes of questions 7--9 between in-clinic and remote patients.

Multivariate model
------------------

[Table 5](#t5-opth-12-2459){ref-type="table"} presents the outcomes of the regression model to predict the response to the question: "Do you feel you were properly consented for surgery?" RLE and LVC data were combined into one model to create a stronger data set. Initially, we explored two separate regression models for RLE and LVC, but the same predictive factors were found in both cases.

Question 4 (postoperative satisfaction with vision) was the major predictor of patient's perception of consent quality, and it was responsible for 80.4% of the variance explained by the regression model. [Figure 3](#f3-opth-12-2459){ref-type="fig"} shows the percentage of patients who were "very satisfied/satisfied", "neither satisfied nor dissatisfied", or "very dissatisfied/dissatisfied" with their postoperative visual outcomes for patients who felt consented properly, and those who did not feel properly consented. Of all patients who did not feel that they were properly consented for their refractive procedure, 32.5% were dissatisfied with the postoperative vision, while only 2.6% of patients were dissatisfied in the group of patients who indicated they were properly consented.

Postoperative visual phenomena (5.8% variance explained, question 6 from [Table 1](#t1-opth-12-2459){ref-type="table"}) and dry eye symptoms (1.0% variance explained) were the other statistically significant factors predicting the consent quality perception. [Figure 4](#f4-opth-12-2459){ref-type="fig"} shows the percentages of patients who had significant difficulties with postoperative glare, halos, starburst, ghosting/double vision, or dry eyes. Between 10.7% and 17.9% (depending on the type of phenomena) of patients who felt they were not properly consented for their procedure had severe postoperative difficulties with visual symptoms or dry eyes, whereas only between 0.7% and 2.3% of patients had significant difficulties in the group of patients who indicated they were "consented properly".

One month postoperative difficulties patients experienced with tasks described in questions 7--9 (night driving, near vision, and distance activities) had also a significant impact on consent quality perception and were responsible for 3.7% of the variance explained by the model. [Figure 5](#f5-opth-12-2459){ref-type="fig"} shows the percentage of patients who had a lot of difficulties or were unable to perform activities because of their vision. A significantly higher proportion of patients (up to 25.7%) who were not satisfied with consent quality experienced postoperative difficulty with one of these tasks.

One-month postoperative binocular UDVA was also a significant predictor of consent satisfaction, accountable for 4.6% of the variance in our multivariate model. As an indication of this relationship, 93.5% of all "consented properly" patients had postoperative binocular UDVA 20/20 or better, whereas this percentage was only 85.0% for patients who felt they were not properly consented. Change between preoperative and postoperative CDVA had a very slight (1.5% of the explained variance), but statistically significant impact on the model. As little as 0.9% of all "consented properly" patients had CDVA reduced by ≥2 lines at the 1-month postoperative visit in either eye and this number was 2.1% for patients who felt they were not properly consented.

Satisfaction with the surgeon's approach (questions 1 and 2, 2.9% of the explained variance) was also a minor but statistically significant factor in the regression model. Of all the "consented properly" patients, 83.8% were "very satisfied" with the surgeon's care, while only 65.2% of patients were "very satisfied" in the group of "not consented properly" patients. A similar relationship was observed in question 2: 82.5% of "consented properly" patients and 61.7% of "not consented properly" patients were "very satisfied" with their surgeon answering all their questions.

The type of consent (in-clinic vs remote) was a statistically significant factor in the univariate model, with in-clinic patients being less satisfied with the consent process compared to remote patients. However, consent type had no impact on the patient's perception of consent quality in the multivariate model.

Discussion
==========

In our study population, the majority of LVC patients and approximately half of the RLE patients preferred a telemedicine consent approach with their surgeon. Remote consenting has many advantages for both -- surgeon and the patient. Surgeons can provide consultations with flexible timetables and locations, even from the comfort of their home.[@b2-opth-12-2459],[@b10-opth-12-2459] Furthermore, teleophthalmology can provide significant savings in time and travel expenses for patients, which could be the reason why it was mostly preferred by the younger population of patients, who may have busier schedules. Previous studies found good agreement between the diagnosis and management decisions by teleophthalmology compared to the diagnosis and management decisions in eye clinics.[@b2-opth-12-2459],[@b5-opth-12-2459],[@b6-opth-12-2459],[@b11-opth-12-2459],[@b12-opth-12-2459] This is mostly because diagnostic imaging and measurements play an important role in ophthalmology[@b4-opth-12-2459] and these can be easily transferred via telemedicine and help in making a diagnosis or deciding on the suitability of candidates for surgery. In our consenting approach, however, the patient is always clinically examined by an ophthalmologist and the final decision to proceed with surgery is always made by the treating surgeon.

In this study, we compared satisfaction of patients who opted for the telemedicine approach and those who preferred to meet their surgeon personally ahead of the surgery day. We found similar satisfaction with the consent process. In the LVC group, 97.5% of in-clinic patients and 98.3% of remote patients indicated that they were properly consented for surgery (*P*=0.04). In the RLE group, 97.6% of in-clinic and 97.9% of remote patients stated their consent process for surgery was adequate (*P*=0.47). The slight statistically significant difference in the LVC group is most likely due to the difference in clinical data between the two groups (eg, in-clinic patients were slightly older and had more challenging preoperative refractive errors), which is the reason why it is necessary to apply a multivariate model to find real factors affecting satisfaction with consent quality.

Similar to our previous publication,[@b8-opth-12-2459] we found that the major factor leading to dissatisfaction with consent quality is not the actual consent type, but an unsatisfactory outcome. The major factor affecting perception of consent quality was the satisfaction with postoperative vision, and it was responsible for 80.4% of the variance explained by our multivariate model. Of all "not consented properly" patients, 32.5% were dissatisfied with vision, whereas as little as 2.6% of patients were dissatisfied with vision if they felt their consent process was adequate. Other, also statistically significant, factors in the model were difficulties with postoperative visual phenomena, dry eyes, difficulties with tasks related to night driving, distance and close-up vision, postoperative binocular UDVA, and change in CDVA. All these suggest that an unsatisfactory postoperative outcome leads patients to believe that they were not properly consented. Satisfaction with surgeon care and surgeons answering questions was also a minor, but statistically significant factor in the model (2.9% of the explained variance); however, the type of consent (remote or in-clinic) had no effect on the patient's perception of consent quality. It is also important to note that there were patients who were satisfied with their visual outcomes but dissatisfied with the consent process. These were perhaps patients who were genuinely dissatisfied with their consent due to a combination of various factors (such as delay in getting an appointment, unhappy with the surgeon's approach, unhappy with service received from the local clinic, long waiting time in the clinic), but still appreciated the visual gain from their refractive surgery. However, the proportion of patients who were dissatisfied with the consent process in our cohort was small (\~2% of all patients included in this study).

Inadequate consenting process has been cited as a major factor in ophthalmology malpractice suits,[@b13-opth-12-2459]--[@b17-opth-12-2459] but it is hardly ever the primary cause of litigation.[@b18-opth-12-2459] It is the poor outcome that primarily leads to litigation in ophthalmology, with the consent process being a secondary factor in claims. Patients have been shown to process information selectively and tend to retain only the facts that are in favor of their decision to proceed with surgery.[@b19-opth-12-2459]--[@b21-opth-12-2459] They often disregard or even deny hearing the risks and adverse events associated with their refractive surgery.[@b19-opth-12-2459]--[@b21-opth-12-2459] To help address this issue, various forms of consenting tools have been proposed to improve the retention of consent information. These mostly consist of a combination of written, verbal, and audiovisual information[@b22-opth-12-2459]--[@b28-opth-12-2459] and can significantly contribute to patients understanding of their medical condition and the proposed surgical procedures.[@b29-opth-12-2459]--[@b33-opth-12-2459]

The consenting process discussed here is multistep and involves written, spoken, and audiovisual delivery of the risks, benefits, and alternatives of surgery. Patients first see a refractive optometrist in their local clinic and have a discussion regarding potential procedures. They then watch a video, which reiterates the information provided by the optometrist, and are provided a written consent form. During the telephone discussion, the surgeon again discusses the risks and benefits of surgery, reviews the information recorded by the optometrist, ensures that the patient can provide informed consent, and answers all questions. The consent process culminates in signing the consent form, where the points of discussion are reiterated, and the patient confirms an understanding of the presented information.

Based on our multivariate model outcomes, we believe that a telemedicine surgeon discussion is essentially equivalent to a face-to-face approach. In fact, telemedicine consenting is increasingly used in various fields of medicine[@b34-opth-12-2459],[@b35-opth-12-2459] and results in high patient satisfaction and significant cost and time savings. Teleconsent was found to combine the convenience and accessibility of obtaining consent remotely with the confidence and value of in-person approach.[@b34-opth-12-2459] Previous studies found no differences in comprehension and patient-reported understanding when comparing telemedicine and face-to-face approaches for delivering informed consent.[@b35-opth-12-2459]

Our study has a few limitations. It is retrospective and the regression model is based on 1-month outcomes, when the healing process may not be completed in all patients. It is also possible that most of the symptoms and side effects subside over time and both CDVA and UDVA improve. For that reason, patients might change their opinion about consent and satisfaction with vision at later follow-ups. However, we feel it is appropriate to ask patients about their experience with the consenting process at early follow-ups, which are attended by the majority of patients. Another advantage of using a 1-month postoperative questionnaire is that patients already experience outcomes of their procedure, but still have some recollection of their preoperative consent information. The questionnaire we used in our study has been previously successfully used in many large population studies.[@b8-opth-12-2459],[@b36-opth-12-2459]--[@b38-opth-12-2459] Another possible limitation of the study is the bias in patient's selection of consent type. There might have been lots of factors that affected the patient's decision to proceed with remote consent, such as work commitments, lifestyle, geographical distance from the nearest clinic, etc. However, the number of patients dissatisfied with the consent process was so low in this study that we believe our consent process (regardless of the type) is adequate and comprehensive.

Conclusion
==========

In conclusion, we believe that remote consenting when utilized as part of a multimodal consent approach for elective refractive surgery can provide patients with an equivalent quality of information as meeting the surgeon personally before the day of their procedure. The telemedicine approach to consenting was eagerly accepted by patients and resulted in high satisfaction. As previously suggested in the literature, a perceived poor outcome is the major cause of dissatisfaction with the consenting process. Reiterating the risks and increasing the patient's understanding of surgery is one of the most important steps in consenting for elective procedures.
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![Postoperative satisfaction with visual acuity: patients who had a remote consent discussion with their surgeon vs patients who had a face-to-face discussion in the clinic.](opth-12-2459Fig1){#f1-opth-12-2459}

![Postoperative difficulties with various tasks: patients who had a remote consent discussion with their surgeon vs patients who had a face-to-face discussion in the clinic.\
**Notes:** (**A**) Laser vision correction patients. (**B**) Refractive lens exchange patients.](opth-12-2459Fig2){#f2-opth-12-2459}

![Postoperative satisfaction with visual acuity for patients who felt they were properly consented for surgery and those who did not feel so.](opth-12-2459Fig3){#f3-opth-12-2459}

![Postoperative difficulties with optical side effects compared between patients who indicated they were "properly consented" vs those who indicated they were "not properly consented" for their refractive procedure. "Significant difficulty": patients who scored 6 or 7 on a scale between 1 (= no difficulty) and 7 (= severe difficulty).](opth-12-2459Fig4){#f4-opth-12-2459}

![Postoperative visual difficulties with various tasks based on patient's perception of consent quality.](opth-12-2459Fig5){#f5-opth-12-2459}

###### 

Patient experience questionnaire

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Postoperative day 1 questionnaire

  Question 1. Overall how satisfied are you with the care that was provided by the surgeon?\
  (1= very satisfied, 2= satisfied, 3= neither, 4= dissatisfied, 5= very dissatisfied)

  Question 2. Overall how satisfied are you that the surgeon answered all of your questions?\
  (1= very satisfied, 2= satisfied, 3= neither, 4= dissatisfied, 5= very dissatisfied)

  One-month postoperative questionnaire

  Question 3. Do you feel you were properly consented for surgery?\
  (1= yes, 2= no)

  Question 4. Thinking about your vision during the last week, how satisfied are you with your vision (without the use of glasses or contact lenses)?\
  (1= very satisfied, 2= satisfied, 3= neither, 4= dissatisfied, 5= very dissatisfied)

  Question 5. Would you recommend vision correction surgery to your friends and relatives?\
  (1= yes, 2= no)

  Question 6. Think about your vision during the last week.\
  Please rate the degree of difficulty you experienced with:\
  • starburst\
  • glare\
  • halos\
  • ghosting/double vision\
  • dry eyes (Measured on a discrete scale from 1= no difficulty to 7= severe difficulty)

  Question 7. Because of your eyesight, how much difficulty do you have with driving at night?\
  (1= no difficulty, 2= a little difficulty, 3= moderate difficulty, 4= a lot of difficulty, 5= never try to do this because of my vision, 6= never do this for other reasons)

  Question 8. Because of your eyesight, how much difficulty do you have in doing work or hobbies that require you to see well up close, such as cooking, fixing things around the house, sewing, using hand tools, or working with a computer?\
  (1= no difficulty, 2= a little difficulty, 3= moderate difficulty, 4= a lot of difficulty, 5= never try to do this because of my vision, 6= never do this for other reasons)

  Question 9. Because of your eyesight, how much difficulty do you have in taking part in active sports or other outdoor activities that you enjoy (like hiking, swimming, aerobics, team sports, or jogging)?\
  (1= no difficulty, 2= a little difficulty, 3= moderate difficulty, 4= a lot of difficulty, 5= never try to do this because of my vision, 6= never do this for other reasons)
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Preoperative and 1-month postoperative clinical outcomes of laser vision correction patients

  Clinical/demographic variable                                                  Consent type In-clinic Remote   *P*-value                     
  ------------------------------------------------------------------------------ ------------------------------- ----------------------------- --------
                                                                                                                                               
  Number of patients                                                             1,626                           6,558                         --
  Female/male ratio                                                              45.8%/54.2%                     47.4%/52.6%                   0.23
  Age[a](#tfn1-opth-12-2459){ref-type="table-fn"}                                34.4±10.8 (18--66)              33.8±10 (18--66)              0.03
                                                                                                                                               
  **Preoperative data[a](#tfn1-opth-12-2459){ref-type="table-fn"}**                                                                            
   Sphere, D                                                                                                                                   
    Myopic sphere                                                                −3.05±2.06                      −2.77±1.84                    \<0.01
    Hyperopic sphere                                                             +1.37±0.95                      +1.46±0.97                    0.15
    Range                                                                        (−11.25 to +4.75)               (−11.00 to +4.75)             
   Cylinder, D                                                                   −0.87±0.85 (0.00 to −6.00)      −0.78±0.72 (0.00 to −6.00)    \<0.01
   CDVA, logMAR                                                                  −0.06±0.06 (0.3 to −0.18)       −0.07±0.05 (0.3 to −0.3)      \<0.01
                                                                                                                                               
  **One-month postoperative data[a](#tfn1-opth-12-2459){ref-type="table-fn"}**                                                                 
   Sphere, D                                                                     +0.05±0.43 (+2.50 to −3.00)     +0.07±0.39 (+2.50 to −3.25)   0.01
   Cylinder, D                                                                   −0.23±0.30 (0 to −3.25)         −0.20±0.26 (0 to −3.50)       \<0.01
   CDVA, logMAR                                                                  −0.08±0.06 (0.3 to −0.3)        −0.09±0.06 (0.52 to −0.3)     \<0.01
   Binocular UDVA, logMAR                                                        −0.11±0.08 (0.52 to −0.3)       −0.09±0.09 (0.7 to −0.3)      \<0.01

**Note:**

These values are given as mean ± SD or mean ± SD (range).

**Abbreviations:** CDVA, corrected distance visual acuity; UDVA, uncorrected distance visual acuity.

###### 

Preoperative and 1-month postoperative clinical outcomes of refractive lens exchange patients

  Clinical/demographic variable                                                  Consent type                  *P*-value                     
  ------------------------------------------------------------------------------ ----------------------------- ----------------------------- --------
                                                                                                                                             
  Number of patients                                                             1,954                         1,800                         --
  Female/male ratio                                                              46.6%/53.4%                   46.9%/53.1%                   0.86
  Age[a](#tfn3-opth-12-2459){ref-type="table-fn"}                                59.6±8.8 (19--88)             58.3±7.4 (21--85)             \<0.01
                                                                                                                                             
  **Preoperative data[a](#tfn3-opth-12-2459){ref-type="table-fn"}**                                                                          
   Sphere, D                                                                                                                                 
    Myopic sphere                                                                −3.87±3.34                    −2.83±2.23                    \<0.01
    Hyperopic sphere                                                             +2.44±1.69                    +2.37±1.44                    0.06
    Range                                                                        (−16.75 to +10.75)            (−15.75 to +10.25)            
   Cylinder, D                                                                   −0.79±0.74 (0 to −6.75)       −0.62±0.55 (0 to −6.50)       \<0.01
   CDVA, logMAR                                                                  −0.02±0.09 (0.3 to −0.18)     −0.04±0.07 (0.3 to −0.18)     \<0.01
                                                                                                                                             
  **One-month postoperative data[a](#tfn3-opth-12-2459){ref-type="table-fn"}**                                                               
   Sphere, D                                                                     +0.03±0.51 (+2.00 to −3.25)   +0.06±0.51 (+2.50 to −3.25)   0.003
   Cylinder, D                                                                   −0.45±0.44 (0 to −4.00)       −0.43±0.40 (0 to −4.00)       0.05
   CDVA, logMAR                                                                  −0.04±0.07 (0.7 to −0.18)     −0.05±0.07 (0.52 to −0.3)     \<0.01
   Binocular UDVA, logMAR                                                        −0.03±0.10 (0.7 to −0.18)     −0.04±0.10 (0.6 to −0.18)     \<0.01

**Note:**

These values are given as mean ± SD or mean ± SD (range).

**Abbreviations:** CDVA, corrected distance visual acuity; UDVA, uncorrected distance visual acuity.

###### 

Visual phenomena and dry eyes

  Postoperative symptoms     Postoperative mean score (mean ± SD)               
  -------------------------- -------------------------------------- ----------- --------
                                                                                
  Laser vision correction                                                       
   Number of patients        1,626                                  6,558       
   Starburst                 1.58±1.13                              1.59±1.16   0.75
   Glare                     1.65±1.14                              1.67±1.16   0.62
   Halo                      1.57±1.12                              1.55±1.10   0.63
   Ghosting/double vision    1.34±0.93                              1.25±0.79   0.0006
   Dry eyes                  1.96±1.31                              1.96±1.29   0.99
  Refractive lens exchange                                                      
   Number of patients        1,954                                  1,800       
   Starburst                 1.85±1.41                              1.89±1.51   0.47
   Glare                     1.96±1.40                              1.96±1.48   0.93
   Halo                      2.00±1.53                              2.00±1.58   0.91
   Ghosting/double vision    1.35±0.93                              1.37±0.99   0.54
   Dry eyes                  1.77±1.23                              1.79±1.24   0.60

**Note:** Each patient rated visual phenomena/dry eye difficulties on a scale from 1 (= no difficulty) to 7 (= severe difficulty) and the mean score for all patients was calculated.

###### 

Results of multivariate regression analysis to predict outcomes of question 3: "Do you feel you were properly consented for surgery?" (*R*^2^=0.33, *P*\<0.0001)

  Independent variable                                                                   Univariate, *P*-value                                   Multivariate, *P*-value                                 Model contribution (%)
  -------------------------------------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- ------------------------
                                                                                                                                                                                                         
  Age at treatment                                                                       \>0.05                                                  --                                                      --
  Gender                                                                                 \>0.05                                                  --                                                      --
  Consent: in-clinic vs remote                                                           0.04[\*](#tfn6-opth-12-2459){ref-type="table-fn"}       \>0.05                                                  --
  Number of days between consent and surgery day                                         \>0.05                                                  --                                                      --
  Type of surgery (LVC or RLE)                                                           \>0.05                                                  --                                                      --
  Preoperative sphere                                                                    \>0.05                                                  --                                                      --
  Preoperative cylinder                                                                  \>0.05                                                  --                                                      --
  Preoperative CDVA                                                                      \>0.05                                                  --                                                      --
  Postoperative sphere                                                                   \>0.05                                                  --                                                      --
  Postoperative cylinder                                                                 0.0003[\*](#tfn6-opth-12-2459){ref-type="table-fn"}     \>0.05                                                  --
  Postoperative binocular UDVA                                                           \<0.0001[\*](#tfn6-opth-12-2459){ref-type="table-fn"}   \<0.0001[\*](#tfn6-opth-12-2459){ref-type="table-fn"}   4.6
  Change in CDVA                                                                         \<0.0001[\*](#tfn6-opth-12-2459){ref-type="table-fn"}   0.003[\*](#tfn6-opth-12-2459){ref-type="table-fn"}      1.5
  Day 1 surgeon care and questions (questions 1 and 2)                                   \<0.0001[\*](#tfn6-opth-12-2459){ref-type="table-fn"}   \<0.0001[\*](#tfn6-opth-12-2459){ref-type="table-fn"}   2.9
  Month 1 satisfaction (question 4)                                                      \<0.0001[\*](#tfn6-opth-12-2459){ref-type="table-fn"}   \<0.0001[\*](#tfn6-opth-12-2459){ref-type="table-fn"}   80.4
  Month 1 impact of eyesight on various activities (questions 7--9)                      \<0.0001[\*](#tfn6-opth-12-2459){ref-type="table-fn"}   \<0.0001[\*](#tfn6-opth-12-2459){ref-type="table-fn"}   3.7
  Month 1 dry eyes (question 6)                                                          \<0.0001[\*](#tfn6-opth-12-2459){ref-type="table-fn"}   0.01[\*](#tfn6-opth-12-2459){ref-type="table-fn"}       1.0
  Month 1 visual symptoms (starburst, glare, halo, ghosting/double vision; question 6)   \<0.0001[\*](#tfn6-opth-12-2459){ref-type="table-fn"}   \<0.0001[\*](#tfn6-opth-12-2459){ref-type="table-fn"}   5.8

**Note:**

Statistically significant.

**Abbreviations:** CDVA, corrected distance visual acuity; LVC, laser vision correction; RLE, refractive lens exchange; UDVA, uncorrected distance visual acuity.
